|
|
|
|
|
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
|
(Address of principal executive offices)
|
|
(Zip code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
1.
|
Election of Class II Directors:
|
|
Number of Shares
|
||
|
For
|
Withheld
|
Broker Non-Votes
|
David Rosa
|
1,812,382
|
159,781
|
683,846
|
Francisco Silva
|
1,951,117
|
21,046
|
683,846
|
2.
|
Approval of amendments to the Company’s 2021 Stock Incentive Plan:
|
For
|
1,790,399
|
Against
|
163,058
|
Abstentions
|
18,706
|
Broker Non-Votes
|
683,846
|
3.
|
Authorization of the reincorporation of the Company from the State of Delaware to the State of Nevada:
|
For
|
1,954,622
|
Against
|
12,382
|
Abstentions
|
5,159
|
Broker Non-Votes
|
683,846
|
4.
|
Approval, on a non-binding advisory basis, of the compensation of the Company’s executive officers:
|
For
|
1,785,569
|
Against
|
169,088
|
Abstentions
|
17,506
|
Broker Non-Votes
|
683,846
|
5.
|
Recommendation, on a non-binding advisory basis, as to frequency of future advisory votes on the Company’s executive compensation:
|
Three Years
|
1,768,754
|
Two Years
|
18,440
|
One Year
|
171,693
|
Abstentions
|
13,276
|
6.
|
Ratification of the selection of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022:
|
For
|
2,636,553
|
Against
|
15,926
|
Abstentions
|
3,530
|
BIORESTORATIVE THERAPIES, INC. |
|||
Dated: November 7, 2022
|
By:
|
/s/ Lance Alstodt |
|
Lance Alstodt |
|||
President and CEO |
|||